MECHANISM OF CYTO-TOXIC ACTIVITY OF 5'-DEOXY-5-FLUOROURIDINE

被引:0
|
作者
ARMSTRONG, RD [1 ]
CONNOLLY, KM [1 ]
KAPLAN, AM [1 ]
CADMAN, E [1 ]
机构
[1] UNIV KENTUCKY,DEPT MED MICROBIOL & IMMUNOL,LEXINGTON,KY 40536
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:102 / 105
页数:4
相关论文
共 50 条
  • [31] ANTICACHECTIC ACTIVITY OF 5'-DEOXY-5-FLUOROURIDINE IN A MURINE TUMOR CACHEXIA MODEL, COLON 26 ADENOCARCINOMA
    TANAKA, Y
    EDA, H
    FUJIMOTO, K
    TANAKA, T
    ISHIKAWA, T
    ISHITSUKA, H
    CANCER RESEARCH, 1990, 50 (15) : 4528 - 4532
  • [32] 5'-DEOXY-5-FLUOROURIDINE - CELLULAR-METABOLISM OF A NEW FLUOROPYRIMIDINE WITH ANTI-NEOPLASTIC ACTIVITY
    ARMSTRONG, RD
    DIASIO, RB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 260 - 260
  • [33] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 2'-AMINO-2'-DEOXY-5-FLUOROURIDINE
    SHARMA, RA
    BOBEK, M
    BLOCH, A
    JOURNAL OF MEDICINAL CHEMISTRY, 1974, 17 (04) : 466 - 468
  • [34] Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5′-deoxy-5-fluorouridine (5′-DFUR)
    Hiromichi Ebi
    Yasushi Sigeoka
    Toshiaki Saeki
    Kenji Kawada
    Tadahiko Igarashi
    Noriko Usubuchi
    Ryuzo Ueda
    Yasutsuna Sasaki
    Hironobu Minami
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 205 - 211
  • [35] STEREOSPECIFIC SYNTHESIS OF THE ANTICANCER AGENT 5'-DEOXY-5-FLUOROURIDINE AND ITS 5'-DEUTERIATED DERIVATIVES
    KISS, J
    DSOUZA, R
    VANKOEVERINGE, JA
    ARNOLD, W
    HELVETICA CHIMICA ACTA, 1982, 65 (05) : 1522 - 1537
  • [36] Chronic Myeloid Leukemia following Chemotherapy with 5′-deoxy-5-fluorouridine for Gastric Cancer
    Tsuzuki, Motohiro
    Handa, Kousuke
    Yamamoto, Kiyoko
    Hasegawa, Akio
    Yamamoto, Yukiya
    Watanabe, Masato
    Mizuta, Syuichi
    Maruyama, Fumio
    Okamoto, Masataka
    Emi, Nobuhiko
    Ezaki, Kohji
    INTERNAL MEDICINE, 2008, 47 (19) : 1739 - 1741
  • [37] Effects of introduction of dThdPase cDNA on sensitivity to 5′-deoxy-5-fluorouridine and tumor angiogenesis
    Kim, R
    Murakami, S
    Toge, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 22 (04) : 835 - 841
  • [38] Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5′-deoxy-5-fluorouridine (5′-DFUR)
    Ebi, H
    Sigeoka, Y
    Saeki, T
    Kawada, K
    Igarashi, T
    Usubuchi, N
    Ueda, R
    Sasaki, Y
    Minami, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (02) : 205 - 211
  • [39] SIMULTANEOUS ANALYSIS OF 5'-DEOXY-5-FLUOROURIDINE AND 5-FLUOROURACIL IN PLASMA BY ANALYTICAL ISOTACHOPHORESIS
    GUSTAVSSON, B
    ALMERSJO, O
    BERNE, M
    WALDENSTROM, J
    JOURNAL OF CHROMATOGRAPHY, 1983, 276 (02): : 395 - 401
  • [40] PHARMACOKINETICS AND METABOLISM OF 5'-DEOXY-5-FLUOROURIDINE (DFUR) AND 5-FLUOROURACIL (FU) IN RATS
    AU, JLS
    WALKER, JS
    SLOCUM, HK
    RUSTUM, YM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 303 - 303